MORGAN STANLEY - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 26 filers reported holding ACHILLES THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$45,513
-33.8%
50,020
-31.2%
0.00%
Q2 2023$68,766
-74.7%
72,753
-74.4%
0.00%
Q1 2023$271,603
+1597.5%
283,659
+3864.5%
0.00%
Q3 2022$16,0000.0%7,155
+12.9%
0.00%
Q2 2022$16,000
-11.1%
6,336
+1.8%
0.00%
Q1 2022$18,000
-43.8%
6,221
-2.0%
0.00%
Q4 2021$32,0006,3490.00%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$10,087,97915.03%
Artal Group S.A. 2,255,375$2,0520.09%
Redmile Group, LLC 1,608,089$1,463,2000.07%
Forefront Analytics, LLC 78,169$71,1260.04%
Baker Brothers Advisors 2,557,149$2,326,7500.01%
Point72 Asset Management, L.P. 1,413,809$1,286,4250.00%
XTX Topco Ltd 21,084$19,1840.00%
Coppell Advisory Solutions LLC 1,000$5,5600.00%
Renaissance Technologies 437,528$3980.00%
JPMORGAN CHASE & CO 989$9000.00%
View complete list of ACHILLES THERAPEUTICS PLC shareholders